Form 8K Silexion Therapeutics
Corp For: 9 November
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Silexion Therapeutics Corp (SLXN)
Silexion Therapeutics Corp stock price live, this page displays NASDAQ SLXN stock exchange data. View the SLXN premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Silexion Therapeutics Corp real time stock price chart below.
What Is the Silexion Therapeutics Corp Stock Price Today?
The Silexion Therapeutics Corp stock price today is 3.0002.
What Is the Stock Symbol for Silexion Therapeutics Corp?
The stock symbol for Silexion Therapeutics Corp is "SLXN."
What Stock Exchange Does Silexion Therapeutics Corp Trade On?
Silexion Therapeutics Corp is listed and trades on the NASDAQ stock exchange.
Is Silexion Therapeutics Corp a Good Stock to Buy?
Determining whether Silexion Therapeutics Corp, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SLXN quote. (ISIN: KYG1281K1638)
What Is the Silexion Therapeutics Corp Stock Price Today?
The Silexion Therapeutics Corp stock price today is 3.0002.
What Is the Stock Symbol for Silexion Therapeutics Corp?
The stock symbol for Silexion Therapeutics Corp is "SLXN."
What Stock Exchange Does Silexion Therapeutics Corp Trade On?
Silexion Therapeutics Corp is listed and trades on the NASDAQ stock exchange.
Is Silexion Therapeutics Corp a Good Stock to Buy?
Determining whether Silexion Therapeutics Corp, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SLXN quote. (ISIN: KYG1281K1638)
3.0002
+0.3602(+13.64%)
Real-time Data·
Fair Value
An estimate of a Silexion Therapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.7065
3.8894
52 wk Range
0.1070
32.3800
Earnings results expected in 7 days
1/2
Fair Value
An estimate of a Silexion Therapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.70653.8894
52 wk Range
0.107032.3800
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
SLXN Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Silexion Therapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
119.9999
Upside
+3,899.73%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in oversold territory
Form 8K Silexion Therapeutics Corp For: 29 September- Investing.com
- Form 8K Silexion Therapeutics Corp For: 9 November
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Strong Buy
Moving Averages
Neutral
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 119.9999
(+3,899.73% Upside)
Earnings
Latest Release
Aug 14, 2026
EPS / Forecast
-5.17 / -13.10
Revenue / Forecast
-- / --
Compare SLXN to Peers and Sector
Metrics to compare | SLXN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSLXNPeersSector | |
|---|---|---|---|---|
P/E Ratio | 0.0x | −1.3x | −0.2x | |
PEG Ratio | - | 0.00 | 0.00 | |
Price/Book | 14.8x | 0.0x | 2.6x | |
Price / LTM Sales | - | 3.6x | 2.8x | |
Upside (Analyst Target) | - | 1,310.3% | 62.3% | |
Fair Value Upside | Unlock | 13.1% | 8.2% | Unlock |
Silexion Therapeutics Corp, a clinical-stage biotechnology company, discovers and develops RNA interference (RNAi) therapies for KRAS-driven cancers. Its products comprise SIL204 second-generation small interfering RNA (siRNA) undergoing phase 2/3 clinical evaluation for pancreatic cancer and silence mutant KRAS oncogene expression. The company was founded in 2008 and is headquartered in Ramat Gan, Israel.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Silexion Therapeutics (SLXN) Stock Price Today?
The Silexion Therapeutics stock price today is 3.0002 USD.
What Stock Exchange Does Silexion Therapeutics Trade On?
Silexion Therapeutics is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Silexion Therapeutics?
The stock symbol for Silexion Therapeutics is "SLXN."
What Is the Silexion Therapeutics Market Cap?
As of today, Silexion Therapeutics market cap is 17.8800M USD.
What Is Silexion Therapeutics's Earnings Per Share (TTM)?
The Silexion Therapeutics EPS (TTM) is -929.85.
When Is the Next Silexion Therapeutics Earnings Date?
Silexion Therapeutics will release its next earnings report on Nov 18, 2026.
From a Technical Analysis Perspective, Is SLXN a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Silexion Therapeutics Stock Split?
Silexion Therapeutics has split 4 times.
How Many Employees Does Silexion Therapeutics Have?
Silexion Therapeutics has 14 employees.
What is the current trading status of Silexion Therapeutics (SLXN)?
As of Nov 11, 2026, Silexion Therapeutics (SLXN) is trading at a price of 3.0002 USD, with a previous close of 2.6400 USD. The stock has fluctuated within a day range of 2.7065 USD to 3.8894 USD, while its 52-week range spans from 0.1070 USD to 32.3800 USD.
What Is Silexion Therapeutics (SLXN) Price Target According to Analysts?
The average 12-month price target for Silexion Therapeutics is 119.9999 USD, with a high estimate of 119.9999 USD and a low estimate of 119.9999 USD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +3,899.73% Upside potential.
What Is the SLXN Premarket Price?
SLXN's last pre-market stock price is 2.7900 USD. The pre-market share volume is 7,680.0000, and the stock has decreased by 0.1500, or 5.6800%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.